Search results for "subcutaneous injection"

AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they have selected the "2026 Health...
When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

Crohn’s disease remains one of the most challenging inflammatory bowel diseases to manage. Patients with refractory—or treatment-resistant—Crohn’s...
GC Wellbeing’s Laennec Injection Clears Phase 3 Hurdle for IV Drip Use, Boosting Growth Prospects

GC Wellbeing’s Laennec Injection Clears Phase 3 Hurdle for IV Drip Use, Boosting Growth Prospects

GC Wellbeing announced on June 16 that it has secured topline results demonstrating that its chronic liver disease...
RNA Therapy Emerges as Critical Fast-Track for Cholesterol Control After Heart Attacks

RNA Therapy Emerges as Critical Fast-Track for Cholesterol Control After Heart Attacks

Myocardial infarction and unstable angina are life-threatening medical emergencies that occur when the blood vessels...
HK inno.N’s Obesity Drug Candidate Outperforms Wegovy in Head-to-Head Phase 2 Trial

HK inno.N’s Obesity Drug Candidate Outperforms Wegovy in Head-to-Head Phase 2 Trial

HK inno.N announced on June 9 that its obesity drug candidate, ecnoglutide, demonstrated superior weight-loss efficacy...
Hurt by Malicious Comments, Actress Ki Eun-se Reveals Bruised Hands After Anti-Aging Procedure

Hurt by Malicious Comments, Actress Ki Eun-se Reveals Bruised Hands After Anti-Aging Procedure

Actress Ki Eun-se, 43, recently revealed that she underwent a cosmetic procedure to reduce wrinkles on her hands after...
Expanded Health Insurance Coverage Lowers Barrier to Care for Rare Heart and Kidney Disorder

Expanded Health Insurance Coverage Lowers Barrier to Care for Rare Heart and Kidney Disorder

Patients suffering from light-chain amyloidosis, a rare and debilitating blood disorder that causes abnormal proteins...
Alteogen to Present Subcutaneous ADC Formulation Research at International Forum in June

Alteogen to Present Subcutaneous ADC Formulation Research at International Forum in June

Alteogen announced on the 23rd that it will present research results regarding subcutaneous dosing for antibody-drug...
Huwons Lab SC Formulation Change Platform, Will It Succeed in the Market?

Huwons Lab SC Formulation Change Platform, Will It Succeed in the Market?

Huwons Global's subsidiary Huwons Lab is challenging the formulation change platform business that converts intravenous...
Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?

Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?

American Biogen and Japanese Eisai are moving quickly to change the formulation and dosage of the dementia treatment...